IDiyas

For the Inventor, By the Inventor

Palo Alto, CA, United States of America

Ying-Zi Xu

USPTO Granted Patents = 35 


 

Average Co-Inventor Count = 7.5

ph-index = 11

Forward Citations = 283(Granted Patents)


Location History:

  • Fremont, CA (US) (2002 - 2010)
  • Palo Alto, CA (US) (2004 - 2016)

Company Filing History:

goldMedal29 out of 202 
 
Elan Pharmaceuticals, Inc.
 patents
silverMedal18 out of 1,309 
 
Wyeth
 patents
bronzeMedal1 out of 5 
 
Imago Pharmaceuticals, Inc.
 patents
4. 4 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2002-2016

Loading Chart...
Loading Chart...
Loading Chart...
35 patents (USPTO):
1. 9493485 - Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereof (2016-11-15),
2. 8367836 - Pyridinone antagonists of alpha-4 integrins (2013-02-05),
3. 8367688 - Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 (2013-02-05),
4. 8158642 - Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 (2012-04-17),
5. 8030328 - Imidazolone phenylalanine derivatives (2011-10-04),
6. 7973044 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2011-07-05),
7. 7968547 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2011-06-28),
8. 7820687 - Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4 (2010-10-26),
9. 7763632 - Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4 (2010-07-27),
10. 7754712 - Bridged N-cyclic sulfonamido inhibitors of gamma secretase (2010-07-13),
11. 7745454 - Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 (2010-06-29),
12. 7741328 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2010-06-22),
13. 7732609 - 5-(arylsulfonyl)-pyrazolopiperidines (2010-06-08),
14. 7727996 - Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 (2010-06-01),
15. 7579466 - Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4 (2009-08-25),

Title: The Innovative Journey of Inventor Ying-Zi Xu

Introduction: Ying-Zi Xu, a talented inventor based in Palo Alto, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Xu's latest patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles, revolutionizing the way we approach transportation and safety on the roads.

Career Highlights: With a background in computer science and engineering, Xu has a proven track record of developing innovative solutions to complex problems. His work has been recognized for its impact on various industries, from healthcare to finance.

Collaborations: Xu has collaborated with leading tech companies and research institutions to further his inventions. His partnerships have led to the development of cutting-edge technologies that are shaping the future of innovation.

Conclusion: Ying-Zi Xu's passion for pushing the boundaries of technology and his dedication to creating solutions that make a difference have solidified his position as a prominent inventor in the tech hub of Palo Alto, CA.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…